2-189110232-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000393.5(COL5A2):c.315C>A(p.Thr105Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.961 in 1,612,522 control chromosomes in the GnomAD database, including 746,605 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.93 ( 66285 hom., cov: 31)
Exomes 𝑓: 0.96 ( 680320 hom. )
Consequence
COL5A2
NM_000393.5 synonymous
NM_000393.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.524
Publications
21 publications found
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 2-189110232-G-T is Benign according to our data. Variant chr2-189110232-G-T is described in ClinVar as Benign. ClinVar VariationId is 439539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.524 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A2 | NM_000393.5 | c.315C>A | p.Thr105Thr | synonymous_variant | Exon 2 of 54 | ENST00000374866.9 | NP_000384.2 | |
| COL5A2 | XM_011510573.4 | c.177C>A | p.Thr59Thr | synonymous_variant | Exon 5 of 57 | XP_011508875.1 | ||
| COL5A2 | XM_047443251.1 | c.177C>A | p.Thr59Thr | synonymous_variant | Exon 7 of 59 | XP_047299207.1 | ||
| COL5A2 | XM_047443252.1 | c.177C>A | p.Thr59Thr | synonymous_variant | Exon 6 of 58 | XP_047299208.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A2 | ENST00000374866.9 | c.315C>A | p.Thr105Thr | synonymous_variant | Exon 2 of 54 | 1 | NM_000393.5 | ENSP00000364000.3 | ||
| COL5A2 | ENST00000649966.1 | c.177C>A | p.Thr59Thr | synonymous_variant | Exon 2 of 11 | ENSP00000496785.1 | ||||
| COL5A2 | ENST00000618828.1 | c.-316C>A | 5_prime_UTR_variant | Exon 2 of 47 | 5 | ENSP00000482184.1 |
Frequencies
GnomAD3 genomes AF: 0.931 AC: 141673AN: 152098Hom.: 66260 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
141673
AN:
152098
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.930 AC: 233806AN: 251280 AF XY: 0.935 show subpopulations
GnomAD2 exomes
AF:
AC:
233806
AN:
251280
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.964 AC: 1407881AN: 1460306Hom.: 680320 Cov.: 34 AF XY: 0.963 AC XY: 699557AN XY: 726558 show subpopulations
GnomAD4 exome
AF:
AC:
1407881
AN:
1460306
Hom.:
Cov.:
34
AF XY:
AC XY:
699557
AN XY:
726558
show subpopulations
African (AFR)
AF:
AC:
28528
AN:
33430
American (AMR)
AF:
AC:
36006
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
25326
AN:
26130
East Asian (EAS)
AF:
AC:
34478
AN:
39692
South Asian (SAS)
AF:
AC:
76703
AN:
86208
European-Finnish (FIN)
AF:
AC:
52796
AN:
53420
Middle Eastern (MID)
AF:
AC:
5329
AN:
5574
European-Non Finnish (NFE)
AF:
AC:
1091081
AN:
1110796
Other (OTH)
AF:
AC:
57634
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2552
5104
7655
10207
12759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21600
43200
64800
86400
108000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.931 AC: 141747AN: 152216Hom.: 66285 Cov.: 31 AF XY: 0.931 AC XY: 69255AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
141747
AN:
152216
Hom.:
Cov.:
31
AF XY:
AC XY:
69255
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
35561
AN:
41514
American (AMR)
AF:
AC:
13442
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
3377
AN:
3472
East Asian (EAS)
AF:
AC:
4686
AN:
5172
South Asian (SAS)
AF:
AC:
4286
AN:
4822
European-Finnish (FIN)
AF:
AC:
10513
AN:
10622
Middle Eastern (MID)
AF:
AC:
284
AN:
294
European-Non Finnish (NFE)
AF:
AC:
66721
AN:
68028
Other (OTH)
AF:
AC:
1965
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
469
937
1406
1874
2343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3121
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
BA1 -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome, classic type, 2 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.